Synchronous bilateral primary germ cell tumors in patient receiving estrogen therapy.
The present report concerns the occurrence of bilateral synchronous germ cell tumors in a sixty-eight-year-old man who received estrogen therapy for eleven months. Although there are previous reports on Leydig cell tumors developing in mice and man receiving estrogens, we have not found any connection between germ cell tumors and estrogen medication reported in the literature.
Hem
E
E
Department of Urology, Rikshospitalet, Oslo, Norway.
Attramadal
A
A
Tveter
K J
KJ
D000368:Aged; D004054:Diethylstilbestrol / Q000009:adverse effects* / Q000627:therapeutic use; D004958:Estradiol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced*; D011108:Polymers / Q000009:adverse effects* / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000628:therapy; D013724:Teratoma / Q000139:chemically induced*; D013736:Testicular Neoplasms / Q000139:chemically induced*; D013997:Time Factors
D011108:Polymers; D004958:Estradiol; D004054:Diethylstilbestrol; C022271:polyestradiol